支气管肺炎是儿童时期的常见病,患病率较高,是儿童住院的首位病种[1],属于我国小儿疾病防治的重点之一,也是威胁儿童生命的主要疾病。在我国,肺炎占住院儿童的24.5%~65.2%,仍然是5岁以下儿童死亡的第一位原因[2]。笔者运用本院自制剂镇咳灵合剂与智能通络仪联合治疗小儿病毒性肺炎取得了一定的疗效,现将结果报道如下。资料与方法1诊断标准1.1西医诊断标准参照《小儿四病防治方案. Bronchopneumonia is a common childhood disease, the prevalence is high, is the first hospitalized children with disease [1], is one of the focus of prevention and treatment of pediatric diseases in our country, but also a major threat to children’s lives. In China, pneumonia accounts for 24.5% to 65.2% of hospitalized children and remains the first cause of death among children under five years of age [2]. The author of the hospital self-made antitussive agent and intelligent meridian joint treatment of children with viral pneumonia has achieved some results, the results reported below. Materials and methods 1 diagnostic criteria 1.1 Western diagnostic criteria with reference to "pediatric four disease prevention and control programs.